Media

Support Of Industry Underscores Pro-Business Commitment
Commercialization of cleaner, safer consumer products through innovative industrial biotechnology processes will be the focus of breakout sessions at the...

Press Releases

Dec 13 2001
WASHINGTON, D.C. - (December 13, 2001) - Sharon L. Cohen, vice president of government relations for the Biotechnology Industry Organization (BIO), released a...
Dec 12 2001
Washington, D.C. (December 12, 2001) - The Biotechnology Industry Organization (BIO) has selected Philadelphia as the site of the BIO 2005 International...
Dec 12 2001
Washington, D.C. (December 12, 2001) - The Biotechnology Industry Organization (BIO) has selected Chicago, Illinois, as the site of the BIO 2006 International...
Dec 6 2001
WASHINGTON, D.C. (December 6, 2001) – The 16th annual International Biotechnology Convention and Exhibition, BIO 2002, will be held June 9-12 at the...
Dec 4 2001
Washington, D.C. (December 4, 2002) - The Biotechnology Industry Organization (BIO) will host the fourth annual CEO & Investor Conference, “Investing...
Nov 29 2001
Washington, D.C. (November 29, 2001) - The Centers for Medicare and Medicaid Services (formerly HCFA) today published a final rule (CMS 1159-2) slashing by 68....
Nov 28 2001
Washington, D.C. (November 28, 2001) - Carl B. Feldbaum, President of the Biotechnology Industry Organization (BIO), today announced management changes and...
Nov 25 2001
Washington, D.C. - In response to today’s announcement by Advanced Cell Technology (ACT) of an apparent cloning of a human embryo, the Biotechnology...
Nov 16 2001
November 16, 2001 (Washington, D.C.) - This week’s 7th Annual BIO-Europe partnering conference set a new record for attendance, drawing more than 1,000...


Biotechnology News

September 22, 2014

LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix International N.V., (NASDAQ:OFIX), a diversified, global medical device company focused on improving patients’ lives by...

September 22, 2014

PALO ALTO, Calif.--(BUSINESS WIRE)--Anacor Pharmaceuticals, Inc. (NASDAQ: ANAC) today announced the U.S. launch of Anacor’s FDA-approved drug KERYDINTM (tavaborole)...

September 22, 2014

ANN ARBOR, Mich.--(BUSINESS WIRE)--Esperion Therapeutics, Inc. (NASDAQ: ESPR) a clinical-stage emerging pharmaceutical company focused on developing and commercializing...

September 22, 2014

LEXINGTON, Mass.--(BUSINESS WIRE)--Xenetic Biosciences, Inc. (OTCBB: XBIO), a biopharmaceutical company focused on developing next-generation biologic drugs and novel...

September 22, 2014

BASKING RIDGE, N.J.--(BUSINESS WIRE)--International Headache Meeting Presentation by electroCore - gammaCore therapy reduces cluster headache by 50%